Skip to content
healthcare.dev

Amantadine Hydrochloride

NDC 16571-834, Amantadine Hydrochloride, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-834
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210129
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-834 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMANTADINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Influenza A M2 Protein Inhibitor [EPC]; M2 Protein Inhibitors [MoA]

Package NDCNDC-11Package
16571-834-0116571083401100 CAPSULE in 1 BOTTLE (16571-834-01)
16571-834-5016571083450500 CAPSULE in 1 BOTTLE (16571-834-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6fd54e00-a714-4442-af95-2515ab3b2ac3
  • NADAC price for package 16571083401

    GET /v1/drugs/nadac/16571083401
  • NADAC price for package 16571083450

    GET /v1/drugs/nadac/16571083450

Use it

Look up 16571-834 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-834 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-834. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.